Item 15. Exhibits, Financial Statement Schedules
22K characters. Original on sec.gov · Markdown
Item 15. Exhibits, Financial Statement Schedules
(a) Documents filed as part of this report:
| (1) | Financial Statements: |
|---|
The consolidated financial statements of the Company and its subsidiaries are filed as part of this Annual Report and are set forth on pages 54 to 99. The report of PricewaterhouseCoopers LLP (PCAOB ID: 238), an independent registered public accounting firm, dated February 25, 2025, is set forth beginning on page 52 of this Annual Report.
| (2) | Exhibits: |
|---|
Table of Contents
Table of Contents
Table of Contents
| + | Paper Filing |
|---|
| * | Management contract or compensatory plan required to be filed as an exhibit to this Annual Report. |
|---|
| ** | This exhibit shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act, or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any filing, except to the extent the Company specifically incorporates it by reference. |
|---|
| (b) | See Item 15 (a) (2) above. |
|---|
| Item 16: | Form 10-K Summary |
|---|
The optional summary in Item 16 has not been included in this Annual Report.
Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| WATERS CORPORATION |
| /s/ Amol Chaubal |
| Amol Chaubal |
| Senior Vice President and Chief Financial Officer |
| (Principal Financial Officer) |
| (Principal Accounting Officer) |
Date: February 25, 2025
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities indicated on February 25, 2025.
| /s/ Dr. Flemming Ornskov, M.D., M.P.H. | Chairman of the Board of Directors | |||
| Dr. Flemming Ornskov, M.D., M.P.H. | ||||
| /s/ Udit Batra, Ph.D. | President and Chief Executive Officer | |||
| Udit Batra, Ph.D. | Director (Principal Executive Officer) | |||
| /s/ Amol Chaubal | Senior Vice President and Chief Financial Officer | |||
| Amol Chaubal | (Principal Financial Officer) | |||
| (Principal Accounting Officer) | ||||
| /s/ Linda Baddour | Director | |||
| Linda Baddour | ||||
| /s/ Dan Brennan | Director | |||
| Dan Brennan | ||||
| /s/ Richard Fearon | Director | |||
| Richard Fearon | ||||
| /s/ Pearl S. Huang, Ph.D. | Director | |||
| Pearl S. Huang, Ph.D. | ||||
| /s/ Wei Jiang | Director | |||
| Wei Jiang | ||||
| /s/ Heather Knight | Director | |||
| Heather Knight | ||||
| /s/ Christopher A. Kuebler | Director | |||
| Christopher A. Kuebler | ||||
| /s/ Mark Vergnano | Director | |||
| Mark Vergnano |